| Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation S Di Agostino, S Strano, V Emiliozzi, V Zerbini, M Mottolese, A Sacchi, ... Cancer cell 10 (3), 191-202, 2006 | 479 | 2006 |
| Mutant p53: an oncogenic transcription factor S Strano, S Dell'Orso, S Di Agostino, G Fontemaggi, A Sacchi, G Blandino Oncogene 26 (15), 2212-2219, 2007 | 359 | 2007 |
| Direct p53 Transcriptional Repression: In Vivo Analysis of CCAAT-Containing G2/M Promoters C Imbriano, A Gurtner, F Cocchiarella, S Di Agostino, V Basile, M Gostissa, ... Molecular and cellular biology 25 (9), 3737-3751, 2005 | 282 | 2005 |
| PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop E Lapi, S Di Agostino, S Donzelli, H Gal, E Domany, G Rechavi, ... Molecular cell 32 (6), 803-814, 2008 | 268 | 2008 |
| miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer A Sacconi, F Biagioni, V Canu, F Mori, A Di Benedetto, L Lorenzon, ... Cell death & disease 3 (11), e423-e423, 2012 | 215 | 2012 |
| New therapeutic strategies to treat human cancers expressing mutant p53 proteins G Blandino, S Di Agostino Journal of Experimental & Clinical Cancer Research 37, 1-13, 2018 | 204 | 2018 |
| YAP enhances the pro‐proliferative transcriptional activity of mutant p53 proteins S Di Agostino, G Sorrentino, E Ingallina, F Valenti, M Ferraiuolo, ... EMBO reports 17 (2), 188-201, 2016 | 193 | 2016 |
| MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function S Donzelli, G Fontemaggi, F Fazi, S Di Agostino, F Padula, F Biagioni, ... Cell Death & Differentiation 19 (6), 1038-1048, 2012 | 172 | 2012 |
| Signaling through extracellular signal-regulated kinase is required for spermatogonial proliferative response to stem cell factor S Dolci, M Pellegrini, S Di Agostino, R Geremia, P Rossi Journal of Biological Chemistry 276 (43), 40225-40233, 2001 | 166 | 2001 |
| Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells S Masciarelli, G Fontemaggi, S Di Agostino, S Donzelli, E Carcarino, ... Oncogene 33 (12), 1601-1608, 2014 | 155 | 2014 |
| Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine C Fiorini, M Cordani, C Padroni, G Blandino, S Di Agostino, M Donadelli Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (1), 89-100, 2015 | 143 | 2015 |
| Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition M Cordani, E Oppici, I Dando, E Butturini, E Dalla Pozza, ... Molecular oncology 10 (7), 1008-1029, 2016 | 132 | 2016 |
| HMGA1 and HMGA2 protein expression in mouse spermatogenesis P Chieffi, S Battista, M Barchi, S Di Agostino, GM Pierantoni, M Fedele, ... Oncogene 21 (22), 3644-3650, 2002 | 122 | 2002 |
| Maize polyamine oxidase: primary structure from protein and cDNA sequencing P Tavladoraki, ME Schininà, F Cecconi, S Di Agostino, F Manera, G Rea, ... FEBS letters 426 (1), 62-66, 1998 | 120 | 1998 |
| Phosphorylation of high-mobility group protein A2 by Nek2 kinase during the first meiotic division in mouse spermatocytes S Di Agostino, M Fedele, P Chieffi, A Fusco, P Rossi, R Geremia, C Sette Molecular biology of the cell 15 (3), 1224-1232, 2004 | 110 | 2004 |
| The mechanism of docosahexaenoic acid-induced phospholipase D activation in human lymphocytes involves exclusion of the enzyme from lipid rafts O Diaz, A Berquand, M Dubois, S Di Agostino, C Sette, S Bourgoin, ... Journal of Biological Chemistry 277 (42), 39368-39378, 2002 | 103 | 2002 |
| The MAPK pathway triggers activation of Nek2 during chromosome condensation in mouse spermatocytes S Di Agostino, P Rossi, R Geremia, C Sette Oxford University Press for The Company of Biologists Limited 129 (7), 1715-1727, 2002 | 101 | 2002 |
| The mutant p53‐ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1 M Pruszko, E Milano, M Forcato, S Donzelli, F Ganci, S Di Agostino, ... EMBO reports 18 (8), 1331-1351, 2017 | 90 | 2017 |
| The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs S Di Agostino, G Cortese, O Monti, S Dell'Orso, A Sacchi, M Eisenstein, ... Cell Cycle 7 (21), 3440-3447, 2008 | 90 | 2008 |
| Oncogenic intra-p53 family member interactions in human cancers M Ferraiuolo, S Di Agostino, G Blandino, S Strano Frontiers in oncology 6, 77, 2016 | 85 | 2016 |
